One telehealth company called CheekyMD advertises its innovative delivery method of a gel meant to dissolve on the inside of the cheek for delivering compounded semaglutide
Although its likely the UK will approve tirzepatide in the not-to-distant future
Based on our study, a GLP-1 receptor agonist-based weight-loss program appears to be superior to non-GLP-1 receptor agonist-based weight-loss programs and intensive lifestyle modification alone for treating post-bariatric surgery weight regain, regardless of surgery type, the researchers wrote
Tirzepatide is a dual-agonist GLP-1 and GIP (glucose-dependent insulinotropic polypeptide) medication that may be prescribed for blood sugar regulation and weight loss
These tend to improve as the body adjusts, especially when following proper injection technique and timing
In June 2025, Amgen announced positive Phase 2 trial results for MariTide showing up to ~20% weight loss in obese patients and ~17% in type 2 diabetes patients, presented at the ADA 85th scientific sessions
